K. Nagashima

发表

Human immunodeficiency virus type 1 entry inhibitors PRO 542 and T-20 are potently synergistic in blocking virus-cell and cell-cell fusion.

D. Thompson, W. Olson, Daniah A. D. Thompson, 2001, The Journal of infectious diseases.

Multiple CCR5 Conformations on the Cell Surface Are Used Differentially by Human Immunodeficiency Viruses Resistant or Sensitive to CCR5 Inhibitors

John P. Moore, R. Berro, T. Hope, 2011, Journal of Virology.

Potent, Broad-Spectrum Inhibition of Human Immunodeficiency Virus Type 1 by the CCR5 Monoclonal Antibody PRO 140

A. Trkola, John P. Moore, T. Ketas, 2001, Journal of Virology.

Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation

A. Murphy, G. Yancopoulos, N. Stahl, 2019, Allergy.

Human immunodeficiency virus type 1 membrane fusion mediated by a laboratory-adapted strain and a primary isolate analyzed by resonance energy transfer

C. Chang, K. Hasel, W. Olson, 1996, Journal of virology.

IL-4 and IL-13, not eosinophils, drive type 2 airway inflammation, remodeling and lung function decline.

Johnathon R. Walls, A. Murphy, G. Yancopoulos, 2022, Cytokine.

Amino-Terminal Substitutions in the CCR5 Coreceptor Impair gp120 Binding and Human Immunodeficiency Virus Type 1 Entry

William C. Olson, Thomas P. Sakmar, A. Trkola, 1998, Journal of Virology.

Differential Inhibition of Human Immunodeficiency Virus Type 1 Fusion, gp120 Binding, and CC-Chemokine Activity by Monoclonal Antibodies to CCR5

William C. Olson, Yong Guo, Jeremy P. Segal, 1999, Journal of Virology.

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

Virginia Litwin, Charmagne Cayanan, R. Koup, 1996, Nature.

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor

J. Moore, T. Sakmar, D. Schols, 1998, Nature Medicine.

Treatment of Advanced Human Immunodeficiency Virus Type 1 Disease with the Viral Entry Inhibitor PRO 542

John P. Moore, C. Petropoulos, T. Ketas, 2004, Antimicrobial Agents and Chemotherapy.

Blocking common γ chain cytokine signaling ameliorates T cell–mediated pathogenesis in disease models

Kaitlyn M. Gayvert, A. Murphy, G. Yancopoulos, 2023, Science Translational Medicine.

Broader Impact of IL-4Rα Blockade than IL-5 Blockade on Mediators of Type 2 Inflammation and Lung Pathology in a House Dust Mite-Induced Asthma Mouse Model

A. Murphy, M. Sleeman, J. Orengo, 2019, C93. MECHANISMS OF AIRWAY INFLAMMATION IN ASTHMA AND COPD.

Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Rα antibody, is required to broadly inhibit type 2 inflammation

A. Murphy, M. Sleeman, Yu Bai, 2020 .

Protection against Clostridium difficile infection with broadly neutralizing antitoxin monoclonal antibodies.

B. Kennedy, A. Marozsan, Paul J Maddon, 2012, The Journal of infectious diseases.

IL-4 And IL-13 Have Distinct And Overlapping Effects On Key Cell Types Involved In The Pathobiology Of Atopic Dermatitis

M. Sleeman, S. Srivatsan, J. Orengo, 2023, Journal of Allergy and Clinical Immunology.